{"transactions":[{"id":4626398,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":false,"shares":5070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."}],"balance_after":1095,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":6165},"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626397,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":100,"price":195.15,"value":19515.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 1,191 restricted stock units."}],"balance_after":4333,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626396,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":194.5887,"value":291883.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades at prices ranging from $194.04 to $194.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4433,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626395,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":2648,"price":193.4392,"value":512227.0016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades at prices ranging from $193.00 to $193.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":5933,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626394,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":4985,"price":192.5387,"value":959805.4195,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades at prices ranging from $192.01 to $192.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":8581,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626393,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":910,"price":191.8521,"value":174585.411,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $191.65 to $191.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":13566,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":4626392,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-24T22:00:04.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":true,"shares":5070,"price":1.12,"value":5678.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026."}],"balance_after":14476,"source":{"system":"sec-edgar","filing":"0001758247-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1758247/000175824726000004/ownership.xml","form_type":"4"}},{"id":728593,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:45:33.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":3127,"derivative":{"exercise_price":162.99,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001610717-26-000287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000287/form4.xml","form_type":"4"}},{"id":728592,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-23T21:45:33.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,191 restricted stock units."}],"balance_after":9406,"source":{"system":"sec-edgar","filing":"0001610717-26-000287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000287/form4.xml","form_type":"4"}},{"id":750007,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:01:37.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":41940,"source":{"system":"sec-edgar","filing":"0001628280-26-040903","document":"wk-form4_1780610493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040903/wk-form4_1780610493.xml","form_type":"4"}},{"id":777560,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:07:43.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":3305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2026, for no consideration."}],"balance_after":62034,"source":{"system":"sec-edgar","filing":"0001758247-26-000002","document":"wk-form4_1778875659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000175824726000002/wk-form4_1778875659.xml","form_type":"4"}},{"id":855442,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-06T23:20:31.000Z","date":"2026-03-04","kind":"gift","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001610717-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000087/form4.xml","form_type":"4"}},{"id":855441,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-06T23:20:31.000Z","date":"2026-03-04","kind":"gift","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,142 restricted stock units."}],"balance_after":8215,"source":{"system":"sec-edgar","filing":"0001610717-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071726000087/form4.xml","form_type":"4"}},{"id":987519,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T21:31:41.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":204.58,"value":1022900.0,"ownership":{"direct":true},"balance_after":58729,"source":{"system":"sec-edgar","filing":"0001758247-25-000006","document":"wk-form4_1764192698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000175824725000006/wk-form4_1764192698.xml","form_type":"4"}},{"id":996332,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:20:06.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":195.87,"value":1958700.0,"ownership":{"direct":true},"balance_after":63729,"source":{"system":"sec-edgar","filing":"0001758247-25-000004","document":"wk-form4_1763500802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000175824725000004/wk-form4_1763500802.xml","form_type":"4"}},{"id":1098955,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T20:24:27.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":11574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":11574,"derivative":{"exercise_price":37.48,"expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":11574},"source":{"system":"sec-edgar","filing":"0001610717-25-000268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000268/form4.xml","form_type":"4"}},{"id":1098954,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-30T20:24:27.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":3142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,142 Restricted Stock Units."}],"balance_after":23215,"source":{"system":"sec-edgar","filing":"0001610717-25-000268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071725000268/form4.xml","form_type":"4"}},{"id":1137819,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:49:40.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":34450,"source":{"system":"sec-edgar","filing":"0001048477-25-000062","document":"wk-form4_1747946974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000062/wk-form4_1747946974.xml","form_type":"4"}},{"id":1143490,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:57:09.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5058,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 15, 2025 for no consideration."}],"balance_after":73729,"source":{"system":"sec-edgar","filing":"0001628280-25-026565","document":"wk-form4_1747688222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025026565/wk-form4_1747688222.xml","form_type":"4"}},{"id":1466981,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T21:09:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date."}],"balance_after":15955,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15955},"source":{"system":"sec-edgar","filing":"0001610717-24-000379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000379/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1466980,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-28T21:09:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,248 restricted stock units (\"RSUs\")."}],"balance_after":20073,"source":{"system":"sec-edgar","filing":"0001610717-24-000379","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000379/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1470307,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T20:20:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":16700,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001610717-24-000356","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000356/form4.xml","form_type":"4"}},{"id":1470306,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-24T20:20:04.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,800 Restricted Stock Units."}],"balance_after":20625,"source":{"system":"sec-edgar","filing":"0001610717-24-000356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071724000356/form4.xml","form_type":"4"}},{"id":1504162,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T21:06:57.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 21, 2024. Price not applicable."}],"balance_after":27800,"source":{"system":"sec-edgar","filing":"0001048477-24-000092","document":"wk-form4_1716498400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000092/wk-form4_1716498400.xml","form_type":"4"}},{"id":1516300,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:15:58.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":13162,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2024 for no consideration."}],"balance_after":68671,"source":{"system":"sec-edgar","filing":"0001628280-24-023557","document":"wk-form4_1715804131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828024023557/wk-form4_1715804131.xml","form_type":"4"}},{"id":1858259,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:15:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":24.84,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001610717-23-000133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000133/form4.xml","form_type":"4"}},{"id":1858258,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-12T20:15:49.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,200 Restricted Stock Units."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001610717-23-000133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000161071723000133/form4.xml","form_type":"4"}},{"id":1880112,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T22:24:19.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 23, 2023. Price not applicable."}],"balance_after":23080,"source":{"system":"sec-edgar","filing":"0001209191-23-031965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123031965/doc4.xml","form_type":"4"}},{"id":1893837,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:20:31.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2023, for no consideration."}],"balance_after":55509,"source":{"system":"sec-edgar","filing":"0001628280-23-018198","document":"wf-form4_168418201428060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828023018198/wf-form4_168418201428060.xml","form_type":"4"}},{"id":2226599,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:04:08.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 16, 2022 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001567619-22-013109","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013109/doc1.xml","form_type":"4"}},{"id":2226598,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T21:04:08.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,200 Restricted Stock Units."}],"balance_after":10625,"source":{"system":"sec-edgar","filing":"0001567619-22-013109","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761922013109/doc1.xml","form_type":"4"}},{"id":2255590,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T00:20:13.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 24, 2022.  Price not applicable."}],"balance_after":18890,"source":{"system":"sec-edgar","filing":"0001567619-22-011786","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922011786/doc1.xml","form_type":"4"}},{"id":2272390,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T22:17:03.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":14645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2022, for no consideration."}],"balance_after":42317,"source":{"system":"sec-edgar","filing":"0001140361-22-019183","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122019183/form4.xml","form_type":"4"}},{"id":2655491,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T21:16:40.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":12659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":12659,"derivative":{"exercise_price":32.93,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":12659},"source":{"system":"sec-edgar","filing":"0001567619-21-012590","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012590/doc1.xml","form_type":"4"}},{"id":2655490,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T21:16:40.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":3617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,617 Restricted Stock Units."}],"balance_after":5425,"source":{"system":"sec-edgar","filing":"0001567619-21-012590","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761921012590/doc1.xml","form_type":"4"}},{"id":2693917,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:12:12.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 25, 2021.  Price not applicable."}],"balance_after":13910,"source":{"system":"sec-edgar","filing":"0001567619-21-011257","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921011257/doc1.xml","form_type":"4"}},{"id":2712671,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-14T20:32:56.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":7558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2021 for no consideration."}],"balance_after":27672,"source":{"system":"sec-edgar","filing":"0001140361-21-017419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121017419/form4.xml","form_type":"4"}},{"id":3006018,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-15T23:15:31.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":4780,"price":45,"value":215100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by David W. Anderson 1996 Irrevocable Trust."}],"balance_after":26990,"source":{"system":"sec-edgar","filing":"0001567619-20-017889","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920017889/doc1.xml","form_type":"4"}},{"id":3006017,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-15T23:15:31.000Z","date":"2020-10-13","kind":"sale","acquired":false,"shares":220,"price":45,"value":9900.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by David W. Anderson 1996 Irrevocable Trust."}],"balance_after":31770,"source":{"system":"sec-edgar","filing":"0001567619-20-017889","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920017889/doc1.xml","form_type":"4"}},{"id":3009804,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T21:06:27.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":5000,"price":40,"value":200000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by David W. Anderson 1996 Irrevocable Trust."}],"balance_after":31990,"source":{"system":"sec-edgar","filing":"0001567619-20-017692","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920017692/doc1.xml","form_type":"4"}},{"id":3103899,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T19:35:45.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":6329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 17, 2020 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":6329,"derivative":{"exercise_price":36.57,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":6329},"source":{"system":"sec-edgar","filing":"0001567619-20-012445","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920012445/doc1.xml","form_type":"4"}},{"id":3103898,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T19:35:45.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-012445","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000156761920012445/doc1.xml","form_type":"4"}},{"id":3131035,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:12:55.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 27, 2020. Price not applicable."}],"balance_after":8790,"source":{"system":"sec-edgar","filing":"0001567619-20-011340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920011340/doc1.xml","form_type":"4"}},{"id":3149264,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T00:57:31.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":8097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2020 for no consideration."}],"balance_after":20114,"source":{"system":"sec-edgar","filing":"0001104659-20-061850","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920061850/a4.xml","form_type":"4"}},{"id":3463792,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-11T22:41:01.000Z","date":"2019-07-09","kind":"grant","acquired":true,"shares":4490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on July 9, 2019 represent a pro rata share of the 2019 annual award for independent directors and vest on June 4, 2020, the same vesting date for the 2019 annual award for all other independent directors."}],"balance_after":4490,"source":{"system":"sec-edgar","filing":"0001567619-19-014685","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919014685/doc1.xml","form_type":"4"}},{"id":3524225,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:16:18.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":6899,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock."}],"balance_after":12017,"source":{"system":"sec-edgar","filing":"0001127430-19-000074","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000074/edgar.xml","form_type":"4"}},{"id":3770740,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T21:06:42.000Z","date":"2018-11-06","kind":"grant","acquired":true,"shares":5118,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on November 6, 2018, for no consideration, and represents a contingent right to receive one share of Common Stock."}],"balance_after":5118,"source":{"system":"sec-edgar","filing":"0001127430-18-000074","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000074/edgar.xml","form_type":"4"}}]}